What ContRoL does

ContRoL (Controlled Release Leaders) is an NSERC CREATE training program hosted at McMaster University in Hamilton, Ontario, established in 2021 under the direction of Professor Todd Hoare. It is a grant-funded academic consortium, not a commercial enterprise, designed to equip Master's, Ph.D., and postdoctoral trainees with both technical and job-ready skills for developing next-generation controlled release vehicles. The program operates as a pan-Canadian network of 9 university partners, 9 industry partners, and 3 non-profit or government organizations, with NSERC providing primary funding through a $1.65 million, six-year grant (2021-2027).

The technical core spans the engineering of delivery vehicles — including hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, triggerable vehicles, implantable devices, muco/tissue adhesives, and bioconjugates — that deliver active agents in a spatially and temporally controlled manner across pharmaceutical, food/nutraceutical, agriculture, medical device, and personal care applications. Recent advances the program integrates include smart materials, self-assembly, targeting, biomanufacturing, statistical optimization, machine learning, and high-throughput screening. The curriculum combines integrative courses (Collaborative Design in Controlled Release; Leadership for Innovation) with design sprints, where solutions are validated with industry and potential customer input, plus industry placements, career mentoring, mentorship circles, entrepreneurship modules, scientific communications training, and lab exchanges.

The business model is grant-based rather than revenue-generating: NSERC CREATE funding covers trainee stipends, internships, communications training, and program administration, while industry partners contribute co-op positions, mentorship, and hands-on training without paying fees. The program's "deliverables" are trained scientists and collaborative research outputs rather than commercial products or services, with trainee recruitment handled by investigators and a program coordinator across partner universities and partnership growth driven through an inquiry form, an Annual General Meeting, and joint events with the Canadian Chapter of the Controlled Release Society.

Name

ContRoL

Legal name

NSERC CREATE Training Program for Controlled Release Leaders (ContRoL)

Website

https://control-create.mcmaster.ca

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

ContRoL is an NSERC CREATE training program at McMaster University that equips Master's, Ph.D., and postdoctoral trainees with technical and industry-ready skills to develop next-generation controlled release vehicles, operating across a pan-Canadian consortium of 9 universities, 9 industry partners, and 3 non-profit/government organizations.

Ownership category

akta.pro rank

Product category

Graduate Research Training Program

NAICS

Professional and Management Development Training (611430)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Controlled release technology
• Graduate research training
• Drug delivery science
• Biomaterials engineering
• Academic workforce development

Headquarters

HQ city

Hamilton

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. NSERC CREATE Grant Funding: The primary funding source is a $1.65 million grant awarded by the Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program. This grant supports research and training in controlled release technology over a six-year period, supplementing students' academic experience with internships, communications training, and other career-ready skills.
2. Industry Partnership Contributions: Industry partners participate by providing co-op positions, on-site hands-on training experiences, mentorship, and collaborative research projects. While partners may help attract partial or full funding subsidies for trainee positions, the program does not charge partners for participation — this is a training cost-sharing model rather than a revenue-generating commercial model.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

ContRoL (Controlled Release Leaders) is an NSERC CREATE Training Program that recruits Master's students, Ph.D. candidates, and postdoctoral fellows across nine Canadian partner universities to develop next-generation controlled release vehicles. The program combines technical training in delivery vehicles (hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, implantable devices, and bioconjugates) with professional skills training, industry placements, design sprints, and entrepreneurship modules for applications spanning pharmaceutical, food/nutraceuticals, agriculture, medical devices, and personal care industries.

Product overview

The NSERC CREATE ContRoL Training Program is a unified training platform that combines multiple components to develop controlled release technology expertise. The core program includes integrative courses ('Collaborative Design in Controlled Release' and 'Leadership for Innovation'), supplemented by Design Sprints for customer-validated solutions, Industry Placements for practical experience, Career Mentoring, a Mentorship Circle connecting trainees with industry leaders, Entrepreneurship Modules, Scientific Communications Training, Industry Skills Workshops, and Lab Exchanges. The program serves Master's students, Ph.D. students, Post-Doctoral Fellows, and Summer Undergraduate students across nine partner universities in Canada, with the goal of producing graduates equipped to lead the development of controlled release vehicles for pharmaceutical, personal care, medical devices, agriculture, and food/nutraceuticals applications.

Differentiator

Problem solved

Functional benefit

Products and services

• NSERC CREATE ContRoL Training Program A six-year graduate training program (2021-2027) that equips Master's, Ph.D., and Post-Doctoral trainees with technical and professional skills to design, fabricate, and translate next-generation controlled release vehicles for pharmaceutical, personal care, medical devices, agriculture, and food/nutraceuticals applications across nine partner Canadian universities.

Quantifiable outcome

• Trainees complete industry placements as an integrated part of their graduate program, gaining hands-on experience outside academia.
• +2 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

20 partnerships are on record, tiered core and minor.

• McMaster UniversitycoreStrategic or Co-development PartnerMcMaster University is the lead institution and headquarters of the ContRoL program. Todd Hoare, Professor and Canada Research Chair in Engineered Smart Materials at McMaster's Department of Chemical Engineering, serves as Program Director. The program is administered from McMaster's campus in Hamilton, Ontario.
• McGill UniversitycoreStrategic or Co-development PartnerMcGill University is a university partner in the ContRoL network. Marta Cerruti, Associate Professor of Materials Engineering and co-Director of the McGill Institute for Advanced Materials, represents McGill as a ContRoL investigator.
• University of GuelphcoreStrategic or Co-development PartnerUniversity of Guelph is a university partner. Iris Joye, Associate Professor of Cereal Chemistry and Biochemistry, serves as a ContRoL investigator contributing expertise in food science applications of controlled release technology.
• University of WaterloocoreStrategic or Co-development PartnerUniversity of Waterloo is a university partner. Emmanuel Ho, Associate Professor at the School of Pharmacy and Department of Chemical Engineering, represents Waterloo as a ContRoL investigator.
• University of TorontocoreStrategic or Co-development PartnerUniversity of Toronto is a university partner. Shirley Wu, Professor at the Leslie Dan Faculty of Pharmacy, serves as a ContRoL investigator.
• Ontario Tech UniversitycoreStrategic or Co-development PartnerOntario Tech University is a university partner. Hendrick de Haan, Associate Professor in the Department of Physics, represents Ontario Tech as a ContRoL investigator.
• Carleton UniversitycoreStrategic or Co-development PartnerCarleton University is a university partner. Maria DeRosa, Professor and Department Chair of Chemistry, represents Carleton as a ContRoL investigator.
• Institut national de la recherche scientifique (INRS)coreStrategic or Co-development PartnerINRS is a university partner based in Montreal. Marc Gauthier, Full Professor at the EMT Research Center, serves as a ContRoL investigator.
• Université de MontréalcoreStrategic or Co-development PartnerUniversité de Montréal is a university partner. Davide Brambilla, Assistant Professor at the Faculté de Pharmacie, represents UdeM as a ContRoL investigator.
• Ripple TherapeuticsminorStrategic or Co-development PartnerRipple Therapeutics is an industry partner in the ContRoL program, participating as a mentor and providing hands-on training experiences for trainees. Focus areas include developing innovative controlled release solutions in the pharmaceutical space.
• 20/20 OptimEyesminorStrategic or Co-development Partner20/20 OptimEyes is an industry partner contributing expertise in ophthalmic applications of controlled release technology. Participates in mentorship, co-op positions, and collaborative research projects.
• GreenMark BiomedicalminorStrategic or Co-development PartnerGreenMark Biomedical is an industry partner focused on biomedical and dental applications of controlled release. Engages with ContRoL trainees through mentorship and collaborative research.
• Sollio AgricultureminorStrategic or Co-development PartnerSollio Agriculture is an industry partner contributing to precision agriculture applications within the ContRoL program. Provides industry perspective and hands-on training opportunities in agricultural controlled release technologies.
• PharmasonicaminorStrategic or Co-development PartnerPharmasonica is an industry partner providing industry discovery activities, placement opportunities, and mentorship for ContRoL trainees in the pharmaceutical space.
• Mannin ResearchminorStrategic or Co-development PartnerMannin Research is an industry partner engaged in collaborative research within the ContRoL controlled release network, contributing biotechnological expertise.
• SuncorminorStrategic or Co-development PartnerSuncor is an industry partner participating in the ContRoL training program, providing industry exposure and potential training experiences for trainees.
• AmacaTheraminorStrategic or Co-development PartnerAmacaThera is an industry partner providing co-op and hands-on training experiences within the ContRoL network, with a focus on pharmaceutical applications of controlled release technology.
• Nanology LabsminorStrategic or Co-development PartnerNanology Labs is an industry partner participating as a mentor and collaborator within the ContRoL training program, contributing pharmaceutical nanotechnology expertise.
• Canadian Chapter of the Controlled Release Society (CC-CRS)coreStrategic or Co-development PartnerCC-CRS is a non-profit partner that collaborates with ContRoL to organize national workshops and networking events, providing partner organizations with national exposure and trainees with professional community connections.
• Agriculture and Agri-Food CanadaminorStrategic or Co-development PartnerAgriculture and Agri-Food Canada is a government partner contributing to the ContRoL network, with particular relevance to agricultural and food/nutraceutical applications of controlled release technology.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Ripple Therapeutics: An industry partner in the ContRoL network and a clinical-stage ophthalmology company developing controlled release therapeutics. Directly comparable as a Canadian controlled release company that benefits from ContRoL's talent pipeline and research collaboration.
• AmacaThera: An industry partner in the ContRoL network developing injectable controlled release hydrogel platforms for pharmaceutical applications. Comparable as a Canadian pharma company leveraging advanced controlled release vehicles, a core subject area of the ContRoL training program.
• GreenMark Biomedical: An industry partner in the ContRoL network developing biomedical and dental applications of controlled release technology. Comparable as a startup commercializing controlled release for medical device and dental indications, overlapping with ContRoL's biomedical segment focus.
• Nanology Labs: An industry partner in the ContRoL network focused on pharmaceutical nanotechnology. Comparable as a Canadian company developing nanoparticle-based drug delivery, intersecting directly with ContRoL's polymer nanoparticle and microneedle training content.
• Mannin Research: An industry partner in the ContRoL network engaged in collaborative biotech research. Comparable as a Canadian biotechnology company participating in the ContRoL consortium for biotechnological applications of controlled release.
• Selecta Biosciences: A clinical-stage biotechnology company developing controlled release immunotherapies using synthetic vaccine particle technology. Comparable as a focused controlled release therapeutics developer, intersecting with ContRoL's pharmaceutical training segment.
• 20/20 OptimEyes: An industry partner in the ContRoL network contributing expertise in ophthalmic applications of controlled release technology. Comparable as a Canadian partner that ContRoL engages with for co-op positions, mentorship, and collaborative research in ophthalmic drug delivery.

Broad incumbents

• Pacira BioSciences: A commercial-stage U.S. pharmaceutical company specializing in non-opioid pain management and other therapeutics using proprietary controlled release technology. Comparable as an established, commercial controlled release drug delivery company at much greater scale than ContRoL's industry partners.
• Evonik Industries: A global specialty chemicals company with a significant pharmaceutical contract development and drug delivery business, including sustained and controlled release excipients. Comparable as a large incumbent operating across multiple controlled release applications including pharma, food, and agriculture.
• Croda International: A global specialty chemicals company with a healthcare-focused drug delivery business supplying excipients and formulation technologies for controlled release. Comparable as a large, established player in controlled release technology across pharma and personal care end-markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nserc-create-training-program-for-controlled-release-leaders-control-
• Instagraminstagram.com/create_control_hqp
• Xx.com/ContRoL_CREATE

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ContRoL